Shanghai Children's Medical Center International Department
Yanjing Tang

Specialist route

Official profile matchedOfficial photo verifiedProfile checked: 2026-04-08

Yanjing Tang

Associate Chief Physician; MD; Deputy Director of the Innovation Diagnosis and Treatment Center

Innovation Diagnosis and Treatment Center, Ward 1 · Shanghai Children's Medical Center International Department

Deputy Director of the Innovation Diagnosis and Treatment CenterAssociate Chief PhysicianMD

The official SCMC page presents Tang Yanjing as a pediatric hematology-oncology specialist focused on relapsed and refractory leukemia, lymphoma, neuroblastoma, and CAR-T immunotherapy.

Use this page to decide whether the specialist direction fits the case, then confirm live appointment availability through the hospital channel.

Expert titles, clinic schedules, and registration availability change quickly. Please treat this page as direction-setting and verify live slots with the official hospital system.

Case fit

Relapsed and refractory pediatric leukemia · Lymphoma · Neuroblastoma · CAR-T immunotherapy

Appointment route

Tuesday morning (VIP clinic, Zhangjiang) · Thursday morning (specialist clinic, Zhangjiang)

Records to prepare

Diagnosis, imaging, surgery notes, lab reports, and treatment history should be organized before booking.

Decide before booking

Start with the disease pattern, age stage, and treatment question. OriEast can turn the records into a concise medical brief before appointment planning.

Clinical snapshot

Innovation Diagnosis and Treatment Center, Ward 1

Shanghai Children's Medical Center International Department

Profile checked: 2026-04-08

Main conditions handled
Relapsed/refractory leukemia · Lymphoma · Neuroblastoma
Best for
Pediatric hematology-oncology · Cell therapy · Immunotherapy
Care approach
CAR-T cell immunotherapy for relapsed or refractory hematologic malignancy

Case fit

Start with the disease pattern, age stage, and treatment question. OriEast can turn the records into a concise medical brief before appointment planning.

Relapsed and refractory pediatric leukemia
Lymphoma
Neuroblastoma
CAR-T immunotherapy

Strong fit for international families seeking advanced cell therapy and CAR-T options for relapsed or refractory pediatric blood cancers or selected solid tumors.

Appointment route

For time-sensitive specialists, the practical path is often official expert clinic, specialty clinic, or the same department team when the top slot is unavailable.

  • Tuesday morning (VIP clinic, Zhangjiang)
  • Thursday morning (specialist clinic, Zhangjiang)

Expert titles, clinic schedules, and registration availability change quickly. Please treat this page as direction-setting and verify live slots with the official hospital system.

Records to prepare

Complete records make the first consultation more efficient, especially for pediatric surgical and specialty cases.

  • Recent outpatient or discharge summaries with confirmed and suspected diagnoses
  • Imaging reports and source files, such as ultrasound, CT, MRI, endoscopy, or echocardiography when relevant
  • Surgery, pathology, genetic, or specialist consultation reports if the child has already been treated
  • Medication, growth, feeding, rehabilitation, and symptom timeline notes
  • A short question list covering the decision you want the specialist to answer

Biography

According to the official page, Tang Yanjing is an associate chief physician, MD, and deputy director of the Innovation Diagnosis and Treatment Center. The page highlights expertise in pediatric benign and malignant blood disease, CAR-T immunotherapy for relapsed or refractory leukemia and lymphoma, and publications in journals such as JCO, Leukemia, Journal of Translational Medicine, and Frontiers in Immunology.

Expertise map

We separate the public profile into disease areas, clinical work, procedures, and academic depth so the page is useful for real appointment decisions.

Specialties

  • Pediatric benign and malignant hematologic disease
  • Relapsed or refractory acute leukemia
  • Lymphoma
  • Neuroblastoma
  • Solid tumors
  • CAR-T cell immunotherapy

Practice Areas

  • Pediatric hematology-oncology
  • Cell therapy
  • Immunotherapy

Conditions Treated

  • Relapsed/refractory leukemia
  • Lymphoma
  • Neuroblastoma
  • Solid tumors

Signature Techniques

  • CAR-T cell immunotherapy for relapsed or refractory hematologic malignancy

Clinical and academic depth

Research focus, roles, awards, and training background help judge whether the specialist has long-term depth in a narrow problem.

Academic Titles

  • Deputy Director of the Innovation Diagnosis and Treatment Center

Leadership Track Record & Contributions

  • Published in major hematology and oncology journals

Research Highlights

  • Research focuses on CAR-T cell immunotherapy for relapsed or refractory pediatric acute leukemia, lymphoma, and solid tumors
  • In recent years, published multiple papers as first or corresponding author in journals including Journal of Clinical Oncology, Leukemia, Journal of Translational Medicine, Frontiers in Immunology, and Cancer Research and Treatment
  • A listed recent project is a National Natural Science Foundation general project on IL-1α released by tumor cell necrosis after leukemia chemotherapy and its role in cardiac energy metabolism dysfunction

Academic Roles

  • Deputy Director of the Innovation Diagnosis and Treatment Center
  • Vice Chair of the Hematology Group of the Pediatrics Specialty Branch of the Shanghai Medical Association
  • Committee member of the Internal Medicine Group of the Pediatric Oncology Committee of the Chinese Anti-Cancer Association
  • Committee member of the Genetics and Gene Therapy Group of the China Eugenics Science Association
  • Secretary of the Pediatric Hematology-Oncology Specialty Group for Shanghai standardized specialist training

Education & Overseas Experience

The reviewed official page did not clearly list overseas training in the excerpt reviewed.

Frequently Asked Questions

Is this expert suitable for a second opinion?

Yes. Yanjing Tang may be a strong option for second-opinion cases involving Pediatric benign and malignant hematologic disease, Relapsed or refractory acute leukemia, Lymphoma, especially when families want input from a leading pediatric center in Shanghai.

What kinds of cases is this expert best for?

This expert is generally best suited for cases involving Relapsed/refractory leukemia, Lymphoma, Neuroblastoma, based on the public SCMC profile and the doctor’s main clinical focus.

Can OriEast help arrange the appointment?

Yes. OriEast can help international families prepare records, confirm booking steps, and coordinate communication with Shanghai Children's Medical Center International Department when arranging care.

What records should patients prepare before booking?

Prepare the latest diagnosis, imaging or pathology reports, treatment summaries, medication list, and any key questions for the specialist. Clear English translations are helpful if available.